Tomesch; John Charles

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tomesch; John Charles.The latest application filed is for "substituted heterocycle fused gamma-carbolines synthesis".

Company Profile

7.13.13

Tomesch; John Charles - Succasunna NJ
Tomesch; John Charles - New York NY US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Hydrochloric acid salt of (6bR,10aS)-3-methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyr- rolo[1,2,3-de]quinoxaline Grant 11,407,751 - Tomesch , et al. August 9, 2	2022-08-09
Preparation of certain substituted 1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof Grant 11,066,407 - Tomesch , et al. July 20, 2	2021-07-20
Substituted Heterocycle Fused Gamma-carbolines Synthesis App 20200115380 - TOMESCH; John Charles ; et al.	2020-04-16
Preparation of certain substituted 1-(4-fluorophenyl)-4-(2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrro- lo[1,2,3-de]quinoxalin-8(7H)-YL)butan-1-ones and pharmaceutically acceptable salts thereof Grant 10,597,395 - Tomesch , et al.	2020-03-24
Substituted Heterocycle Fused Gamma-carbolines Synthesis App 20200087305 - TOMESCH; John Charles ; et al.	2020-03-19
Pharmaceutical compositions comprising ((6bR,10aS)-1-(4-fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-p- yrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one or pharmaceutically acceptable salts thereof Grant 10,464,938 - Tomesch , et al. No	2019-11-05
Substituted Heterocycle Fused Gamma-carbolines Synthesis App 20190292185 - TOMESCH; John Charles ; et al.	2019-09-26
Substituted Heterocycle Fused Gamma-carbolines Synthesis App 20190218219 - TOMESCH; John Charles ; et al.	2019-07-18
Preparation of certain substituted [((6bR,10aS)-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,- 2,3-de]quinoxalines and pharmaceutically acceptable salts thereof Grant 10,221,176 - Tomesch , et al.	2019-03-05
Substituted Heterocycle Fused Gamma-carbolines Synthesis App 20180044337 - TOMESCH; John Charles ; et al.	2018-02-15
Preparation of certain [((6BR,10AS)-2,3,6B,7,8,9,10, 10A-octahydro-1H-pyrido[3',4':4,5]pyrrolo [1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof Grant 9,751,883 - Tomesch , et al. September 5, 2	2017-09-05
Substituted Heterocycle Fused Gamma-carbolines Synthesis App 20160194326 - TOMESCH; John Charles ; et al.	2016-07-07
Substituted pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders Grant 9,371,324 - Mates , et al. June 21, 2	2016-06-21
Preparation of 4-((6BR,10AS)-3-methyl-2,3,6B,9,10, 10A-hexahydro-1H-pyrido[3',4':4,5]pyrrolo [1,2,3-de]quinoxalin-8-(7H)-yl)-1-(4-fluorophenyl)-1-butanone or a pharmaceutically acceptable salt thereof Grant 9,315,504 - Tomesch , et al. April 19, 2	2016-04-19
Organic Compounds App 20150166540 - MATES; Sharon ; et al.	2015-06-18
Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines derivatives and [1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole derivatives Grant 8,993,572 - Mates , et al. March 31, 2	2015-03-31
Substituted Heterocycle Fused Gamma-carbolines Synthesis App 20140364609 - TOMESCH; John Charles ; et al.	2014-12-11
Substituted 2,3,4,4A,5,9B-hexahydro-1H-pyrido[4,3-B]indole derivatives synthesis and uses thereof Grant 8,779,139 - Tomesch , et al. July 15, 2	2014-07-15
Organic Compounds App 20130202692 - Mates; Sharon ; et al.	2013-08-08
Substituted Heterocycle Gamma-carbolines Synthesis App 20130046097 - TOMESCH; John Charles ; et al.	2013-02-21
Substituted heterocycle gamma-carbolines synthesis Grant 8,309,722 - Tomesch , et al. November 13, 2	2012-11-13
Substituted Heterocycle Gamma-carbolines Synthesis App 20100113781 - Tomesch; John Charles ; et al.	2010-05-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.